[O-][n+]1c2c([n+]([O-])c3ccccc31)-c1cccc3cccc-2c13
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?